Very early development of typical signs of Kawasaki Disease with transient coronary involvement.

Danilo Buonsenso, Sebastian Cristaldi, Antonino Reale, Isabella Tarissi de Jacobis, Laura Granata, Alessandra Marchesi
  • Danilo Buonsenso
    Danilo Buonsenso, MD, Catholic University of Sacred Heart—A. Gemelli Hospital, Department of Pediatrics, Pediatric Infectious Disease Unit, Largo A. Gemelli 8, 00168 Rome, Italy. E-mail:, Italy |
  • Sebastian Cristaldi
    Ospedale Pediatrico Bambino Gesù, Roma, Italy
  • Antonino Reale
    Ospedale Pediatrico Bambino Gesù, Roma, Italy
  • Isabella Tarissi de Jacobis
    Ospedale Pediatrico Bambino Gesù, Roma, Italy
  • Laura Granata
    Ospedale Pediatrico Bambino Gesù, Roma, Italy
  • Alessandra Marchesi
    Ospedale Pediatrico Bambino Gesù, Roma, Italy


Kawasaki disease (KD) is an acute, self-limited, inflammatory disease affecting medium-sized arteries and particularly the coronary arteries in about 25% of untreated cases. KD is a clinical diagnosis based on the presence of ≥5 days of fever and the presence of ≥4 of the 5 principal clinical criteria. We described, for the first time to our knowledge, a case of a very early development (on day 1) of typical KD with transient coronary involvement, diagnosed on day 2 of disease and treated with aspirin and steroids on day 3, with complete resolution of clinical signs and coronary involvement.


kawasaki disease, coronary artery

Full Text:

Submitted: 2018-02-08 01:36:24
Published: 2018-06-20 00:00:00
Search for citations in Google Scholar
Related articles: Google Scholar


- Kuo HC, Hsu YW, Wu MS, et al. Intravenous immunoglobulin, pharmacogenomics, and Kawasaki disease. J. Microbiol. Immunol. Infect. 2016;49:1e7.

- Moffett BS, Syblik D, Denfield S, et al. Epidemiology of immunoglobulin resistant Kawasaki disease: results from a large, national database. Pediatr. Cardiol. 2015;36:374e8.

- Nakamura Y, Yashiro M, Uehara R, et al. Epidemiologic features of Kawasaki disease in Japan: results of the 2009e2010 nationwide survey. J. Epidemiol. 2012;22:216e21.

- Kim GB, Han JW, Park YW, et al. Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009-2011. Pediatr. Infect. Dis. J. 2014;33:24-7

- Falcini F, Capannini S, Rigante D. Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas. Pediatr. Rheumatol. 2011;9:17.

- Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110:2747–2771.

- McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation. 2017;135:e927–e999

- Shulman ST. Is there a role for corticosteroids in Kawasaki disease? J. Pediatr. 2003;142:601–603.

- Yang TJ, Lin MT, Lu CY, et al. The prevention of coronary arterial abnormalities in Kawasaki disease: A meta-analysis of the corticosteroid effectiveness. J. Microbiol. Immunol. Infect. 2017;S1684-1182(17)30195-0.

- Pinches H, Dobbins K, Cantrell S, et al. Asymptomatic Kawasaki Disease in a 3-Month-Old Infant. Pediatrics. 2016;138(2):e20153936

Abstract views:


Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM

Copyright (c) 2018 Mediterranean Journal of Hematology and Infectious Diseases

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
© PAGEPress 2008-2018     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185     •     Privacy